Explore how CRISPR/Cas9 gene editing is revolutionizing cancer treatment through precision genetic modifications, immune cell engineering, and targeted therapies.
Exploring how super-enhancers drive cancer progression by hijacking gene regulation and the latest therapeutic approaches targeting them.
Exploring how reversible epigenetic changes control cancer progression, therapy resistance, and the promise of epigenetic treatments.
Exploring how Master's students critically analyze immunological research, from lab protocols to clinical trial data in cancer immunotherapy.
Exploring how epigenetic modifications act as master manipulators in cancer progression and the revolutionary new paths for detection and treatment.
Exploring epigenetic therapies that reprogram cancer cells by targeting DNA methylation, histone modifications, and other regulatory mechanisms.